Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
Total Valuation
GoodRx Holdings has a market cap or net worth of $760.52M. The enterprise value is $558.51M.
Market Cap$760.52M
Enterprise Value$558.51M
Share Statistics
GoodRx Holdings has 108,610,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding108,610,310
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
GoodRx Holdings’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 9.16%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)9.16%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee1.08M
Profits Per Employee33.89K
Employee Count738
Asset Turnover0.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GoodRx Holdings is 31.7. GoodRx Holdings’s PEG ratio is 0.31.
PE Ratio31.7
PS Ratio1.21
PB Ratio1.57
Price to Fair Value1.57
Price to FCF5.87
Price to Operating Cash Flow4.52
PEG Ratio0.31
Income Statement
In the last 12 months, GoodRx Holdings had revenue of 796.85M and earned 30.44M in profits. Earnings per share was 0.09.
Revenue796.85M
Gross Profit654.13M
Operating Income106.97M
Pretax Income56.54M
Net Income30.44M
EBITDA184.36M
Earnings Per Share (EPS)0.09
Cash Flow
In the last 12 months, operating cash flow was 167.90M and capital expenditures -59.43M, giving a free cash flow of 108.47M billion.
Operating Cash Flow167.90M
Free Cash Flow108.47M
Free Cash Flow per Share1.00
Dividends & Yields
GoodRx Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.62
52-Week Price Change-50.45%
50-Day Moving Average2.41
200-Day Moving Average3.55
Relative Strength Index (RSI)47.24
Average Volume (3m)4.05M
Important Dates
GoodRx Holdings upcoming earnings date is May 7, 2026, Before Open (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
GoodRx Holdings as a current ratio of 2.61, with Debt / Equity ratio of 9.66%
Current Ratio2.61
Quick Ratio2.61
Debt to Market Cap0.06
Net Debt to EBITDA-1.10
Interest Coverage Ratio2.51
Taxes
In the past 12 months, GoodRx Holdings has paid -26.10M in taxes.
Income Tax-26.10M
Effective Tax Rate-0.46
Enterprise Valuation
GoodRx Holdings EV to EBITDA ratio is 4.14, with an EV/FCF ratio of 4.64.
EV to Sales0.96
EV to EBITDA4.14
EV to Free Cash Flow4.64
EV to Operating Cash Flow4.55
Balance Sheet
GoodRx Holdings has $261.82M in cash and marketable securities with $59.54M in debt, giving a net cash position of $202.28M billion.
Cash & Marketable Securities$261.82M
Total Debt$59.54M
Net Cash$202.28M
Net Cash Per Share$1.86
Tangible Book Value Per Share$0.34
Margins
Gross margin is 82.09%, with operating margin of 13.42%, and net profit margin of 3.82%.
Gross Margin82.09%
Operating Margin13.42%
Pretax Margin7.10%
Net Profit Margin3.82%
EBITDA Margin23.14%
EBIT Margin12.44%
Analyst Forecast
The average price target for GoodRx Holdings is $2.82, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$2.82
Price Target Upside27.03% Upside
Analyst ConsensusHold
Analyst Count12
Revenue Growth Forecast1.30%
EPS Growth Forecast―